Webinar: SEP-1 Is Changing. How Leaders Are Navigating 2026 Performance.

Hear how clinical, quality, and operational leaders are approaching early sepsis decisions under VBP pressure.  REGISTER HERE

Press Releases

Cytovale Completes $100 Million Series D Funding to Accelerate Commercial Expansion of its Rapid Sepsis Solution